Sirtuins' control of autophagy and mitophagy in cancer

Michele Aventaggiato1, Enza Vernucci2, Federica Barreca1

  • 1Department of Experimental Medicine, Sapienza University, Viale Regina Elena 324, 00161 Rome, Italy.

Pharmacology & Therapeutics
|November 27, 2020
PubMed

Insights

Sirtuins regulate autophagy and mitophagy, cellular processes exploited by cancer cells. Understanding this link offers new avenues for anti-cancer therapies targeting cellular metabolism.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Autophagy and mitophagy are crucial cellular degradation pathways.
  • Cancer cells hijack these pathways for growth and survival.
  • Sirtuins are key regulators of cellular stress responses and metabolism.

Purpose of the Study:

  • To review the role of sirtuins, autophagy, and mitophagy in cancer.
  • To elucidate how sirtuins control autophagy and mitophagy in cancer cells.
  • To discuss the therapeutic potential of targeting sirtuins in cancer treatment.

Main Methods:

  • Literature review of sirtuin, autophagy, and mitophagy research in cancer.
  • Analysis of molecular mechanisms linking sirtuins to autophagy/mitophagy regulation.
  • Discussion of metabolic pathways, including glutamine metabolism, as targets.

Main Results:

  • Sirtuins modulate autophagy and mitophagy through gene transcription and protein modification.
  • Sirtuins influence cancer cell metabolism, affecting autophagy and mitophagy.
  • Targeting sirtuins can disrupt cancer cell growth by controlling these degradation pathways.

Conclusions:

  • Sirtuins play a critical role in regulating autophagy and mitophagy in cancer.
  • Interplay between sirtuins and these pathways presents promising anti-cancer therapeutic strategies.
  • Modulating sirtuins offers a novel approach to control cancer cell metabolism and progression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.6K